MTORC1 is essential for early steps during schwann cell differentiation of amniotic fluid stem cells and regulates lipogenic gene expression

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Preitschopf, Andrea ^a   Li, Kongzhao ^a,b   Schörghofer, David ^a   Kinslechner, Katharina ^a   Schütz, Birgit ^a   Pham, Ha Thi Thanh ^a   Rosner, Margit ^a   Joo, Gabor Jozsef ^c   Röhrl, Clemens ^a   Weichhart, Thomas ^a   Stangl, Herbert ^a   Lubec, Gert ^b   Hengstschläger, Markus ^a   Mikula, Mario ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIV KLIN KINDER JUGENDHEILKUNDE   (Austria)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; PROTEIN S100B; STEROL REGULATORY ELEMENT BINDING PROTEIN; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MTOR PROTEIN, HUMAN; MULTIPROTEIN COMPLEX; TARGET OF RAPAMYCIN KINASE;

AMNION FLUID; AMNIOTIC FLUID STEM CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; FLUORESCENCE; GENE ACTIVATION; GENE EXPRESSION; GENETIC TRANSFECTION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE; IN VIVO STUDY; MOUSE; MUTANT; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SCHWANN CELL; SCIATIC NERVE; SIGNAL TRANSDUCTION; STEM CELL; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; LIPOGENESIS; METABOLISM; PHYSIOLOGY;

AMNIOTIC FLUID; ANIMALS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; HUMANS; LIPOGENESIS; MICE, INBRED C57BL; MULTIPROTEIN COMPLEXES; SCHWANN CELLS; SIGNAL TRANSDUCTION; STEM CELLS; TOR SERINE-THREONINE KINASES;

EID: 84907150479     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107004     Document Type: Article

References (40)

1. Sherman DL, Krols M, Wu LM, Grove M, Nave KA, et al. (2012) Arrest of myelination and reduced axon growth when Schwann cells lack mTOR. J Neurosci 32: 1817-1825.
2. Martin I, Nguyen TD, Krell V, Greiner JF, Muller J, et al. (2012) Generation of Schwann cell-derived multipotent neurospheres isolated from intact sciatic nerve. Stem Cell Rev 8: 1178-1187.
3. Liang C, Tao Y, Shen C, Tan Z, Xiong WC, et al. (2012) Erbin is required for myelination in regenerated axons after injury. J Neurosci 32: 15169-15180.
4. Ladak A, Olson J, Tredget EE, Gordon T (2011) Differentiation of mesenchymal stem cells to support peripheral nerve regeneration in a rat model. Exp Neurol 228: 242-252.
5. Prusa AR, Marton E, Rosner M, Bernaschek G, Hengstschlager M (2003) Oct- 4-expressing cells in human amniotic fluid: a new source for stem cell research? Hum Reprod 18: 1489-1493.
6. In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, Noort WA, Claas FH, et al. (2003) Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 102: 1548-1549.
7. Prusa AR, Marton E, Rosner M, Bettelheim D, Lubec G, et al. (2004) Neurogenic cells in human amniotic fluid. Am J Obstet Gynecol 191: 309-314.
8. Tsai MS, Lee JL, Chang YJ, Hwang SM (2004) Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel twostage culture protocol. Hum Reprod 19: 1450-1456.
9. Kim J, Lee Y, Kim H, Hwang KJ, Kwon HC, et al. (2007) Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Prolif 40: 75-90.
10. De Coppi P, Bartsch G Jr, Siddiqui MM, Xu T, Santos CC, et al. (2007) Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25: 100-106.
11. Valli A, Rosner M, Fuchs C, Siegel N, Bishop CE, et al. (2010) Embryoid body formation of human amniotic fluid stem cells depends on mTOR. Oncogene 29: 966-977.
12. Brohlin M, Mahay D, Novikov LN, Terenghi G, Wiberg M, et al. (2009) Characterisation of human mesenchymal stem cells following differentiation into Schwann cell-like cells. Neurosci Res 64: 41-49.
13. Tian X, Wang S, Zhang Z, Lv D (2012) Rat bone marrow-derived Schwann-like cells differentiated by the optimal inducers combination on microfluidic chip and their functional performance. PLoS One 7: e42804.
14. Leblanc SE, Srinivasan R, Ferri C, Mager GM, Gillian-Daniel AL, et al. (2005) Regulation of cholesterol/lipid biosynthetic genes by Egr2/Krox20 during peripheral nerve myelination. J Neurochem 93: 737-748.
15. Verheijen MH, Camargo N, Verdier V, Nadra K, de Preux Charles AS, et al. (2009) SCAP is required for timely and proper myelin membrane synthesis. Proc Natl Acad Sci U S A 106: 21383-21388.
16. Sharpe LJ, Brown AJ (2013) Controlling cholesterol synthesis beyond 3-hydroxy- 3-methylglutaryl-CoA reductase (HMGCR). J Biol Chem 288: 18707-18715.
17. Bakan I, Laplante M (2012) Connecting mTORC1 signaling to SREBP-1 activation. Curr Opin Lipidol 23: 226-234.
18. Chen WQ, Siegel N, Li L, Pollak A, Hengstschlager M, et al. (2009) Variations of protein levels in human amniotic fluid stem cells CD117/2 over passages 5-25. J Proteome Res 8: 5285-5295.
19. Swoboda A, Schanab O, Tauber S, Bilban M, Berger W, et al. (2012) MET expression in melanoma correlates with a lymphangiogenic phenotype. Hum Mol Genet 21: 3387-3396.
20. Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to Image J: 25 years of image analysis. Nat Methods 9: 671-675.
21. Fuchs C, Rosner M, Dolznig H, Mikula M, Kramer N, et al. (2012) Tuberin and PRAS40 are anti-apoptotic gatekeepers during early human amniotic fluid stemcell differentiation. Hum Mol Genet 21: 1049-1061.
22. Siegel N, Rosner M, Unbekandt M, Fuchs C, Slabina N, et al. (2010) Contribution of human amniotic fluid stem cells to renal tissue formation depends on mTOR. Hum Mol Genet 19: 3320-3331.
23. Calandra S, Tarugi P, Speedy HE, Dean AF, Bertolini S, et al. (2011) Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk. J Lipid Res 52: 1885-1926.
24. King RH, Chandler D, Lopaticki S, Huang D, Blake J, et al. (2011) Ndrg1 in development and maintenance of the myelin sheath. Neurobiol Dis 42: 368-380.
25. Bilheimer DW, Grundy SM, Brown MS, Goldstein JL (1983) Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes. Proc Natl Acad Sci U S A 80: 4124-4128.
26. Schalm SS, Tee AR, Blenis J (2005) Characterization of a conserved C-terminal motif (RSPRR) in ribosomal protein S6 kinase 1 required for its mammalian target of rapamycin-dependent regulation. J Biol Chem 280: 11101-11106.
27. Schalm SS, Blenis J (2002) Identification of a conserved motif required for mTOR signaling. Curr Biol 12: 632-639.
28. Caddick J, Kingham PJ, Gardiner NJ, Wiberg M, Terenghi G (2006) Phenotypic and functional characteristics of mesenchymal stem cells differentiated along a Schwann cell lineage. Glia 54: 840-849.
29. Fu Q, Goodrum JF, Hayes C, Hostettler JD, Toews AD, et al. (1998) Control of cholesterol biosynthesis in Schwann cells. J Neurochem 71: 549-555.
30. Wegner M (2000) Transcriptional control in myelinating glia: flavors and spices. Glia 31: 1-14.
31. Heller BA, Ghidinelli M, Voelkl J, Einheber S, Smith R, et al. (2014) Functionally distinct PI 3-kinase pathways regulate myelination in the peripheral nervous system. J Cell Biol 204: 1219-1236.
32. Sheean ME, McShane E, Cheret C, Walcher J, Muller T, et al. (2014) Activation of MAPK overrides the termination of myelin growth and replaces Nrg1/ErbB3 signals during Schwann cell development and myelination. Genes Dev 28: 290-303.
33. Chrast R, Saher G, Nave KA, Verheijen MH (2011) Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models. J Lipid Res 52: 419-434.
34. Boyles JK, Zoellner CD, Anderson LJ, Kosik LM, Pitas RE, et al. (1989) A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest 83: 1015-1031.
35. Zhao S, Hu X, Park J, Zhu Y, Zhu Q, et al. (2007) Selective expression of LDLR and VLDLR in myelinating oligodendrocytes. Dev Dyn 236: 2708-2712.
36. Maier O, De Jonge J, Nomden A, Hoekstra D, Baron W (2009) Lovastatin induces the formation of abnormal myelin-like membrane sheets in primary oligodendrocytes. Glia 57: 402-413.
37. Murinson BB, Haughey NJ, Maragakis NJ (2012) Selected statins produce rapid spinal motor neuron loss in vitro. BMC Musculoskelet Disord 13: 100.
38. Paintlia AS, Paintlia MK, Khan M, Vollmer T, Singh AK, et al. (2005) HMGCoA reductase inhibitor augments survival and differentiation of oligodendrocyte progenitors in animal model of multiple sclerosis. FASEB J 19: 1407-1421.
39. Peterson TR, Sengupta SS, Harris TE, Carmack AE, Kang SA, et al. (2011) mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. Cell 146: 408-420.
40. Myckatyn TM, Ellis RA, Grand AG, Sen SK, Lowe JB, 3rd, et al. (2002) The effects of rapamycin in murine peripheral nerve isografts and allografts. Plast Reconstr Surg 109: 2405-2417.